Michael Allen Jerman Alaunos Therapeutics, Inc. (TCRT) insider trading activity

Michael Allen Jerman is of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 9,589 shares of TCRT, which is worth approximately $28,479. The most recent transaction as insider was on Jan 12, 2026, when has been sold 5,406 shares (Common Stock) at a price of $2.89 per share, resulting in proceeds of $15,623. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.59K

n/a 3M change

n/a 12M change

Total Value Held $28,479

Michael Allen Jerman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 12 2026	BUY Grant, award, or other acquisition	$15,623 $2.89 p/Share	5,406 Added 36.05%	9,589 Common Stock
Nov 21 2025	BUY Grant, award, or other acquisition	$13,218 $3.16 p/Share	4,183 Added 50.0%	4,183 Common Stock

Also insider at

INTI

Inhibitor Therapeutics, Inc. Healthcare

Director

MIRA

MIRA PHARMACEUTICALS, INC.

Director

TELO

Telomir Pharmaceuticals, Inc.

Director

MAJ